tiprankstipranks
Trending News
More News >

Revolution Medicines price target lowered to $72 from $73 at H.C. Wainwright

H.C. Wainwright analyst Robert Burns lowered the firm’s price target on Revolution Medicines (RVMD) to $72 from $73 and keeps a Buy rating on the shares following the Q1 report. The firm is factoring in higher operating expenses moving forward.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue